EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy

Antonio Ballesteros-Ribelles iD, Alejandro Millán-López iD, MDolores Carmona-Luque iD, Concha Herrera iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115769 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Antonio Ballesteros-Ribelles und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Group, Maimonides Institute for Biomedical Research, 14004 Córdoba, Spain. Hauptthemen laut MEDLINE: Granulocyte Colony-Stimulating Factor, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphocyte collection by apheresis for CAR-T production usually does not include blood mobilized using granulocyte colony stimulating factor (G-CSF) due to the widespread knowledge that it causes a decrease in the number and functionality of lymphocytes. However, it is used for stem cell transplant, which is a common treatment for hematological malignancies. The growing demand for CAR therapies (CAR-T and NK-CAR), both in research and clinics, makes it necessary to evaluate whether mobilized PBSC products may be potential candidates for use in such therapies. This review collects recent works that experimentally verify the role and functionality of T and NK lymphocytes and the generation of CAR-T from apheresis after G-CSF mobilization. As discussed, T cells do not vary significantly in their phenotype, the ratio of CD4+ and CD8+ remains constant, and the different sub-populations remain stable. In addition, the expansion and proliferation rates are invariant regardless of mobilization with G-CSF as well as the secretion of proinflammatory cytokines and the cytotoxic ability. Therefore, cells mobilized before apheresis are postulated as a new alternative source of T cells for adoptive therapies that will serve to alleviate high demand, increase availability, and take advantage of the substantial number of existing cryopreserved products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte Colony-Stimulating FactorReceptors, Chimeric AntigenImmunotherapy, AdoptiveHumansLeukocytes, MononuclearHematopoietic Stem Cell MobilizationKiller Cells, NaturalT-LymphocytesAnimals

Stichwörter der Autor:innen

CAR-NKCAR-TG-CSFmobilization

Substanzen

Granulocyte Colony-Stimulating FactorReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Cell Therapy Group, Maimonides Institute for Biomedical Research, 14004 Córdoba, Spain.
  • Department of Hematology, Reina Sofia University Hospital, 14004 Córdoba, Spain.
  • Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain.

ORCID-Profile: Antonio Ballesteros-Ribelles, Alejandro Millán-López, MDolores Carmona-Luque, Concha Herrera

Zitieren

APA

Ballesteros-Ribelles, A., Millán-López, A., Carmona-Luque, M., & Herrera, C. (2024). Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115769

Vancouver

Ballesteros-Ribelles A, Millán-López A, Carmona-Luque M, Herrera C. Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115769

BibTeX
@article{BallesterosRibelles2024,
  author = {Ballesteros-Ribelles, Antonio and Millán-López, Alejandro and Carmona-Luque, MDolores and Herrera, Concha},
  title = {Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115769}
}
Kostenlos starten →